PCM
Peregrine Capital Management’s Exact Sciences EXAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.7M | Buy |
822,617
+117,331
| +17% | +$6.23M | 1.32% | 16 |
|
|
2025
Q1 | $30.5M | Sell |
705,286
-24,454
| -3% | -$1.06M | 1.01% | 22 |
|
|
2024
Q4 | $41M | Sell |
729,740
-34,478
| -5% | -$1.94M | 1.21% | 19 |
|
|
2024
Q3 | $52.1M | Sell |
764,218
-4,422
| -0.6% | -$301K | 1.57% | 14 |
|
|
2024
Q2 | $32.5M | Buy |
768,640
+114,047
| +17% | +$4.82M | 0.95% | 22 |
|
|
2024
Q1 | $45.2M | Sell |
654,593
-4,110
| -0.6% | -$284K | 1.3% | 17 |
|
|
2023
Q4 | $48.7M | Buy |
658,703
+96,778
| +17% | +$7.16M | 1.46% | 14 |
|
|
2023
Q3 | $38.3M | Sell |
561,925
-563
| -0.1% | -$38.4K | 1.14% | 17 |
|
|
2023
Q2 | $52.8M | Sell |
562,488
-6,009
| -1% | -$564K | 1.44% | 10 |
|
|
2023
Q1 | $38.5M | Sell |
568,497
-36,959
| -6% | -$2.51M | 1.11% | 14 |
|
|
2022
Q4 | $30M | Buy |
605,456
+165,439
| +38% | +$8.19M | 0.94% | 18 |
|
|
2022
Q3 | $14.3M | Sell |
440,017
-5,941
| -1% | -$193K | 0.46% | 45 |
|
|
2022
Q2 | $17.6M | Sell |
445,958
-23,058
| -5% | -$908K | 0.53% | 36 |
|
|
2022
Q1 | $32.8M | Sell |
469,016
-42,323
| -8% | -$2.96M | 0.78% | 24 |
|
|
2021
Q4 | $39.8M | Buy |
511,339
+132,382
| +35% | +$10.3M | 0.8% | 25 |
|
|
2021
Q3 | $36.2M | Buy |
378,957
+31,501
| +9% | +$3.01M | 0.75% | 26 |
|
|
2021
Q2 | $43.2M | Buy |
347,456
+43,521
| +14% | +$5.41M | 0.77% | 26 |
|
|
2021
Q1 | $40.1M | Buy |
303,935
+21,595
| +8% | +$2.85M | 0.74% | 19 |
|
|
2020
Q4 | $37.4M | Buy |
282,340
+39,371
| +16% | +$5.22M | 0.71% | 24 |
|
|
2020
Q3 | $24.8M | Buy |
+242,969
| New | +$24.8M | 0.66% | 41 |
|